EPISODE · Dec 8, 2021 · 25 MIN
A review of Baloxavir®, an antiviral treatment for influenza A and B.
Dr. Rupeena Purewal, pediatric infectious disease physician, reviews Balxoavir Marboxil®, an oral antiviral medication for treatment of influenza A and influenza B flu. Baloxavir® was approved for medical use in Canada in 2020.Canadian Baloxavir Product Monograph : [Product Monograph Template - Standard] (hres.ca)
Embed this episode
Ready to play
A review of Baloxavir®, an antiviral treatment for influenza A and B.
0:00
25:46
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of The Canadian Breakpoint?
This episode is 25 minutes long.
When was this The Canadian Breakpoint episode published?
This episode was published on December 8, 2021.
Is there a transcript available for this episode?
Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.
Can I download this The Canadian Breakpoint episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!